Tokuhon Licenses Pain Patch Chinese Rights To Hong Kong Firm
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Tokuhon has licensed rights to market two anti-inflammatory analgesic patch formulations of flurbiprofen to GC-Rice Pharmaceutical of Hong Kong